Online citations, reference lists, and bibliographies.
← Back to Search

A Window Into The Brain: Tools To Assess Pre-clinical Efficacy Of Biomaterials-based Therapies On Central Nervous System Disorders.

J. Samal, A. L. Rebelo, A. Pandit
Published 2019 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Therapeutic conveyance into the brain is a cardinal requirement for treatment of diverse central nervous system (CNS) disorders and associated pathophysiology. Effectual shielding of the brain by the blood-brain barrier (BBB) sieves out major proportion of therapeutics with the exception of small lipophilic molecules. Various nano-delivery systems (NDS) provide an effective solution around this obstacle owing to their small size and targeting properties. To date, these systems have been used for several pre-clinical disease models including glioma, neurodegenerative diseases and psychotic disorders. An efficacy screen for these systems involves a test battery designed to probe into the multiple facets of therapeutic delivery. Despite their wide application in redressing various disease targets, the efficacy evaluation strategies for all can be broadly grouped into four modalities, namely: histological, bio-imaging, molecular and behavioural. This review presents a comprehensive insight into all of these modalities along with their strengths and weaknesses as well as perspectives on an ideal design for a panel of tests to screen brain nano-delivery systems.
This paper references
10.2174/1381612823666170111112550
Mass Spectrometry Imaging in Nanomedicine: Unraveling the Potential of MSI for the Detection of Nanoparticles in Neuroscience.
F. Barré (2017)
NIH Swiss and Black Swiss mice have retinal degeneration and performance deficits in cognitive tests.
Steven J Clapcote (2005)
10.1016/j.ijpharm.2010.05.005
Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
Chun-Yang Zhuang (2010)
10.2147/IJN.S138501
Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue
X. Zhang (2017)
10.1038/sj.jcbfm.9600034
Atorvastatin Induction of VEGF and BDNF Promotes Brain Plasticity after Stroke in Mice
J. Chen (2005)
10.1039/c0nr00345j
Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study.
Fernanda Sousa (2010)
10.1523/JNEUROSCI.23-36-11411.2003
Treadmill Locomotion in the Intact and Spinal Mouse
H. Leblond (2003)
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease.
K. Jellinger (1995)
10.1007/BF00232445
Inaccuracy and instability of sequential movements in Parkinson's disease
K. E. Martin (2004)
10.2147/IJN.S104162
c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma
Yukun Huang (2016)
10.1007/s11095-010-0265-9
Poly(ε-caprolactone)-Block-poly(ethyl Ethylene Phosphate) Micelles for Brain-Targeting Drug Delivery: In Vitro and In Vivo Valuation
P. Zhang (2010)
10.1002/smll.201701921
Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.
Yung-Hao Tsou (2017)
10.1083/jcb.201009132
Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model
Wonseok Choi (2011)
10.1016/j.ejphar.2008.08.011
Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT(1A) antipsychotic compounds.
R. Depoortère (2008)
10.1016/j.ijpharm.2014.05.056
Albumin nanoparticles for the delivery of gabapentin: preparation, characterization and pharmacodynamic studies.
B. Wilson (2014)
10.1016/j.ijpharm.2011.07.036
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery.
A. Trapani (2011)
10.1007/s00280-015-2926-1
Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes
Q. Lin (2015)
10.1155/2014/156010
Formulation and Optimization of Polymeric Nanoparticles for Intranasal Delivery of Lorazepam Using Box-Behnken Design: In Vitro and In Vivo Evaluation
D. Sharma (2014)
10.1101/LM.2.6.299
Integration of olfactory information in a spatial representation enabling accurate arm choice in the radial arm maze.
P. Lavenex (1996)
10.1016/0165-0270(95)00049-6
Quantitative measurement of muscle strength in the mouse
J. Smith (1995)
10.1016/j.ejpb.2010.12.016
Haloperidol-loaded polysorbate-coated polymeric nanocapsules increase its efficacy in the antipsychotic treatment in rats.
D. Benvegnú (2011)
10.1093/SCHBUL/SBL060
Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures.
B. Turetsky (2007)
10.1016/j.brainres.2009.01.011
Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model
Chunxia Wang (2009)
10.2147/CPAA.S12082
Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
R. Kones (2010)
10.1038/s41598-017-11611-4
Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: An in vitro-in vivo study
K. R. Gajbhiye (2017)
10.1007/s12010-011-9383-z
Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional Platforms
A. Fernandez-Fernandez (2011)
Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
L. Dépatie (2001)
10.1016/j.biomaterials.2009.08.049
Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Weilun Ke (2009)
10.1111/J.1600-0773.1997.TB00040.X
Undernutrition during suckling changes the sensitivity to haloperidol and chlorpromazine in two behavioural measures in weaning rats.
J. Rocha (1997)
10.1208/aapsj060323
Etoposide-incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies
L. H. Reddy (2008)
10.1016/j.nurx.2006.08.001
Behavioral tests for preclinical intervention assessment
T. Schallert (2011)
10.1016/0014-4886(69)90128-9
A permanent change in brain function resulting from daily electrical stimulation.
G. V. Goddard (1969)
10.1016/S0166-4328(02)00279-6
Inbred mouse strain differences in the establishment of long-term fear memory
S. Balogh (2003)
10.1166/JBN.2015.2082
Nanoencapsulation Improves Relative Bioavailability and Antipsychotic Effect of Olanzapine in Rats.
F. Dimer (2015)
10.1073/PNAS.0509425103
In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space.
R. Thorne (2006)
10.1016/j.lfs.2016.08.033
Development of risperidone liposomes for brain targeting through intranasal route.
Reema Narayan (2016)
10.2147/IJN.S82481
Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs
C. Wang (2015)
10.1166/JNN.2016.11103
Neuroprotective Potential of Superparamagnetic Iron Oxide Nanoparticles Along with Exposure to Electromagnetic Field in 6-OHDA Rat Model of Parkinson's Disease.
Preeti Umarao (2016)
10.1016/j.ijpharm.2011.12.009
Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
Ming-Jun Tsai (2012)
10.1016/j.neuron.2006.11.025
Persistence of Long-Term Memory Storage Requires a Late Protein Synthesis- and BDNF- Dependent Phase in the Hippocampus
P. Bekinschtein (2007)
10.5582/ddt.2015.01016
Liposome encapsulated of temozolomide for the treatment of glioma tumor: preparation, characterization and evaluation.
J. Gao (2015)
10.1016/j.talanta.2017.11.067
Silver nanoparticles as matrix for MALDI FTICR MS profiling and imaging of diverse lipids in brain.
M. Guan (2018)
10.3791/2376
Assessment of motor balance and coordination in mice using the balance beam.
T. N. Luong (2011)
10.1093/neuonc/nop054
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
S. Kunwar (2010)
10.1177/0885328211429495
Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood–brain barrier
Yung-Chu Chen (2013)
10.1016/j.ijpharm.2011.05.044
Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake.
R. Tiwari (2011)
10.1016/j.nbd.2009.07.028
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
R. Gabathuler (2010)
10.1021/ac300374x
Three-dimensional atlas of iron, copper, and zinc in the mouse cerebrum and brainstem.
D. Hare (2012)
10.1021/nn506408v
Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.
Richa Pahuja (2015)
10.1517/17425247.2015.1018175
Polymeric nanoparticle drug delivery technologies for oral delivery applications
Eric M. Pridgen (2015)
10.1016/j.msec.2017.08.049
Superparamagnetic iron oxide nanoparticles modified with dimyristoylphosphatidylcholine and their distribution in the brain after injection in the rat substantia nigra.
Lichao Su (2017)
10.1111/apha.12515
Biological and physiological role of reactive oxygen species – the good, the bad and the ugly
L. Zuo (2015)
10.1016/j.pbb.2016.09.003
Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery
Nia M. Harris (2016)
10.4155/bio.14.280
MALDI-MS imaging for the study of tissue pharmacodynamics and toxicodynamics.
E. Patel (2015)
10.1016/j.ejpb.2008.03.009
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.
B. Wilson (2008)
10.3109/10717544.2014.975382
Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study
Rohini G Madane (2016)
10.1371/journal.pone.0148848
Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats
Yingzheng Zhao (2016)
10.1016/j.jconrel.2014.07.050
The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease.
C. Zhang (2014)
10.1039/c7bm01088e
A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model.
Xiaonan Tan (2018)
10.1089/neu.2007.0452
Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions.
J. Tsenter (2008)
10.1016/j.jconrel.2011.05.010
Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
Stefanie Wohlfart (2011)
10.1073/PNAS.91.6.2076
Convection-enhanced delivery of macromolecules in the brain.
R. Bobo (1994)
10.1016/0006-2952(61)90145-9
A new and rapid colorimetric determination of acetylcholinesterase activity.
G. Ellman (1961)
10.1080/10837450.2016.1226901
Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines
Nargess Gandomi (2017)
10.1523/JNEUROSCI.13-10-04181.1993
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
M. F. Beal (1993)
10.1038/s41467-017-00622-4
A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol
Chia-Jung Chang (2017)
10.2217/nnm.14.165
Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism.
Gabriela da Rocha Lindner (2015)
10.3109/10717544.2015.1038857
Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy
Z. Chen (2016)
10.1038/NCHEMBIO782
Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate α-synuclein fibrilization
D. A. Bosco (2006)
10.1016/j.nano.2013.07.003
Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma.
G. Bernal (2014)
10.1016/j.physbeh.2009.09.005
A revised Racine's scale for PTZ-induced seizures in rats
A. Lüttjohann (2009)
10.1016/J.IT.2007.01.005
Astrocytes are active players in cerebral innate immunity.
C. Farina (2007)
10.1016/0031-9384(93)90050-P
Lasting effects on rodent anxiety of a single exposure to a cat
R. Adamec (1993)
10.2147/DDDT.S93937
Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil
Abdulrahman K Al Asmari (2016)
10.1016/0014-2999(78)90118-8
Behavioural despair in rats: a new model sensitive to antidepressant treatments.
R. Porsolt (1978)
10.3390/ijms18030628
PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
Bhairavi Srinageshwar (2017)
10.1523/JNEUROSCI.18-10-03659.1998
Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia
S. Namura (1998)
10.1016/j.addr.2010.05.006
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
M. Mahmoudi (2011)
10.1016/0006-8993(95)00023-J
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
J. Kreuter (1995)
10.1111/J.1365-201X.1971.TB10999.X
Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.
U. Ungerstedt (1971)
10.2147/IJN.S87336
Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer’s disease: pharmaceutical, biological, and toxicological studies
Y. S. Elnaggar (2015)
10.1146/ANNUREV.NEURO.28.061604.135718
Molecular pathophysiology of Parkinson's disease.
D. Moore (2005)
10.1021/ac800904g
Silver nanoparticles as selective ionization probes for analysis of olefins by mass spectrometry.
Stacy D. Sherrod (2008)
10.1089/10430340360464660
Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.
Y. Zhang (2003)
10.1016/J.YMTHE.2005.09.014
Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes.
A. Judge (2006)
10.1073/pnas.1701911114
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression
D. Yu (2017)
10.1007/s00216-015-8858-0
Recent advances in quantitative LA-ICP-MS analysis: challenges and solutions in the life sciences and environmental chemistry
A. Limbeck (2015)
10.1016/j.addr.2012.09.036
Quantum dots as a platform for nanoparticle drug delivery vehicle design.
C. Probst (2013)
10.1038/s41598-017-03123-y
Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier
X. Meng (2017)
10.1016/j.ejps.2011.07.007
Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
H. Chen (2011)
10.1016/j.jtemb.2018.10.021
LA-ICP-MS/MS improves limits of detection in elemental bioimaging of gadolinium deposition originating from MRI contrast agents in skin and brain tissues.
David Clases (2019)
10.1016/j.apsb.2016.02.001
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
Dinh Ha (2016)
10.1016/j.jsps.2011.04.001
Nanoparticles: Emerging carriers for drug delivery.
S. R. Mudshinge (2011)
10.1016/j.biomaterials.2013.03.030
Silica-coated superparamagnetic iron oxide nanoparticles targeting of EPCs in ischemic brain injury.
Q. Li (2013)
10.2174/1874205X01610010136
The Role of the Iron Stain in Assessing Intracranial Hemorrhage
R. Castellani (2016)
10.1016/0091-3057(80)90353-6
Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPA
F. Hefti (1980)
10.2147/IJN.S123422
Angiopep-2-conjugated poly(ethylene glycol)-co- poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
F. Lu (2017)
10.1016/j.biomaterials.2008.08.004
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs.
K. S. Rao (2008)
10.1177/0269881105048890
Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies
I. Aasen (2005)
10.1038/nprot.2009.148
Mouse closed head injury model induced by a weight-drop device
M. Flierl (2009)
Early pathologic detection of acute myocardial infarction.
R. Kloner (1981)
10.1016/j.neuro.2013.07.010
Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb).
S. W. Bihaqi (2013)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/j.jconrel.2011.07.030
In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.
A. Estella-Hermoso de Mendoza (2011)
10.1016/j.ijpharm.2015.07.075
Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies.
E. B. Basalious (2015)
10.1080/10717544.2017.1309476
Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies
Sara Nageeb El-Helaly (2017)
10.1039/C5RA19793G
Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment
S. Singh (2016)
10.1016/S0928-0987(97)10020-3
Evaluation of the formalin test to assess the analgesic activity of diflunisal in the rat.
C. J. Meunier (1998)
10.1088/0957-4484/27/17/175101
Protective role of free and quercetin-loaded nanoemulsion against damage induced by intracerebral haemorrhage in rats.
A. R. Galho (2016)
10.1016/J.JCONREL.2006.01.005
Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes.
T. Ishida (2006)
10.1016/j.ejpb.2015.05.019
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
S. Di Gioia (2015)
10.1007/BF00518192
Modulation of social memory in male rats by neurohypophyseal peptides
R. Dantzer (2004)
In vitro release performance and analgesic activity of endomorphin-1 loaded nanoparticles.
H. Liu (2006)
10.1080/10717544.2016.1199609
Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury
I. Khalin (2016)
10.1056/NEJMRA022366
Apoptosis and caspases in neurodegenerative diseases.
R. Friedlander (2003)
10.1016/j.ijpharm.2015.04.049
Effect of Baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia-reperfusion in rats.
Zhidong Liu (2015)
10.1017/S0033291700051485
Stereotyped responding by schizophrenic patients on a two-choice guessing task.
C. Frith (1983)
10.1111/j.2042-7158.2010.01225.x
Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery
S. Dhawan (2011)
10.1021/bc200406n
In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.
Juyoun Jin (2011)
10.1007/BF00427696
Parametric influences on catalepsy
P. Sanberg (2004)
10.1007/s12640-009-9087-0
Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease
R. Prediger (2009)
10.1038/sj.mp.4001159
Mouse genetic models for prepulse inhibition: an early review
M A Geyer (2002)
10.1016/j.anorl.2011.03.002
Anatomy and physiology of cerebrospinal fluid.
L. Sakka (2011)
10.1089/hum.2009.087
Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo.
Lei Han (2010)
10.2147/IJN.S35333
Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer’s disease models
A. Bernardi (2012)
10.1042/BJ0990667
Mechanisms of lipid peroxide formation in animal tissues.
E. D. Wills (1966)
10.1016/J.NANTOD.2011.10.001
Toxicology and clinical potential of nanoparticles
L. Yildirimer (2011)
10.1159/000136485
Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite.
D. Jollow (1974)
10.1016/j.expneurol.2004.09.005
Testing forelimb placing “across the midline” reveals distinct, lesion-dependent patterns of recovery in rats
M. Woodlee (2005)
10.3758/BF03200795
Quantification of swim patterns in the morris water maze
S. Dalm (2000)
10.1016/J.PROGPOLYMSCI.2007.05.017
Biodegradable polymers as biomaterials
L. Nair (2007)
10.1016/J.IJPHARM.2005.11.040
Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
K. Gao (2006)
10.1002/jps.24557
Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity.
Y. Elnaggar (2015)
10.1371/journal.pone.0042597
Local Delivery of Nimodipine by Prolonged-Release Microparticles—Feasibility, Effectiveness and Dose-Finding in Experimental Subarachnoid Hemorrhage
D. Hänggi (2012)
10.1016/j.ejps.2010.03.007
Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.
H. Chen (2010)
10.1016/j.neubiorev.2009.02.001
Top–down modulation of prepulse inhibition of the startle reflex in humans and rats
L. Li (2009)
10.1093/gerona/glt188
Clinically relevant frailty index for mice.
Haiming M Liu (2014)
10.1002/jps.22285
Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations.
Ming-Jun Tsai (2011)
10.1016/s0304-3959(02)00457-8
Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats
E. C. Stoffel (2003)
10.1016/j.jconrel.2008.08.014
Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.
A. L. Cardoso (2008)
10.1016/j.bbadis.2013.10.015
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.
X. Wang (2014)
10.1080/10717544.2016.1223216
Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies
S. Nour (2016)
10.1016/j.drudis.2010.08.009
The MPTP marmoset model of parkinsonism: a multi-purpose non-human primate model for neurodegenerative diseases.
I. Philippens (2010)
10.1038/266730A0
Depression: a new animal model sensitive to antidepressant treatments
R. Porsolt (1977)
10.1248/CPB.58.1423
Chitosan nanoparticles: a promising system in novel drug delivery.
K. Nagpal (2010)
10.3109/10717544.2015.1058434
Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery
Miaojing Wu (2016)
10.1016/j.biomaterials.2011.03.047
A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA.
D. Hwang (2011)
10.7150/thno.22164
Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes
Yuan-Chin Hsieh (2018)
10.1016/j.bbr.2012.01.016
Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease
A. A. Castro (2012)
10.1155/2013/316523
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Y. Zhao (2013)
10.1021/nn405077y
Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway.
S. Tiwari (2014)
10.1523/JNEUROSCI.4246-09.2009
A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection
H. Karatas (2009)
10.1016/j.biopha.2008.01.017
Glutathione and Parkinson's disease: is this the elephant in the room?
G. Zeevalk (2008)
A method for the routine assessment of fore- and hindlimb grip strength of rats and mice.
Meyer Oa (1979)
10.1093/JN/134.3.489
Glutathione metabolism and its implications for health.
G. Wu (2004)
10.1016/S0166-4328(01)00309-6
Behavioral phenotyping of the MPTP mouse model of Parkinson's disease
M. Sedelis (2001)
10.1016/j.jconrel.2015.03.033
Exosomes as drug delivery vehicles for Parkinson's disease therapy.
M. Haney (2015)
10.1002/jnr.20280
Peroxide detoxification by brain cells
R. Dringen (2005)
10.1016/j.nbd.2009.09.015
Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE2 activation
W. Chiu (2010)
10.1111/cns.12580
Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood–Brain Barrier in a Rat Model of Parkinson's Disease
Young-sook Kang (2016)
10.1007/s12274-017-1924-5
Customized lipid-coated magnetic mesoporous silica nanoparticle doped with ceria nanoparticles for theragnosis of intracerebral hemorrhage
Bong Geun Cha (2018)
10.1002/POLB.22259
Biomedical Applications of Biodegradable Polymers.
B. Ulery (2011)
10.1016/S0165-0270(02)00114-0
A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia
L. Zhang (2002)
10.1002/chem.201404562
Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.
N. Gao (2015)
10.1093/ANNONC/MDG374
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions.
A. Chanan-Khan (2003)
10.1016/j.jconrel.2010.06.018
Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Kun Shao (2010)
10.1016/0006-8993(91)90864-R
Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating
K. Stevens (1991)
10.1517/17425240902758188
Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases
Thomas M. Barchet (2009)
10.1016/j.ejpb.2013.08.011
Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
S. Martins (2013)
10.1038/mt.2012.161
Genetically Engineered Microvesicles Carrying Suicide mRNA/Protein Inhibit Schwannoma Tumor Growth
A. Mizrak (2013)
10.1039/C6DT03351B
Characterization and utilization of Prussian blue and its pigments.
F. Grandjean (2016)
10.2217/nnm-2016-0413
Expanding the potential of MRI contrast agents through multifunctional polymeric nanocarriers.
I. Craciun (2017)
10.1002/(SICI)1097-4547(19970515)48:4<287::AID-JNR1>3.0.CO;2-7
Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice
F. Pitossi (1997)
10.2147/IJN.S120939
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
Chenchen Bi (2016)
10.1016/S0024-3205(99)00619-0
Body distribution of 3H-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after i.v. injections to mice.
U. Schroeder (2000)
10.1002/mds.20700
Long‐term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study
W. Poewe (2006)
10.1177/0271678X15608201
Internalization of targeted quantum dots by brain capillary endothelial cells in vivo
Sarah Paris-Robidas (2016)
10.1016/S0028-3932(01)00223-8
Impaired fear conditioning in Alzheimer’s disease
S. Hamann (2002)
10.1038/nnano.2017.133
Electromagnetized gold nanoparticles mediate direct lineage reprogramming into induced dopamine neurons in vivo for Parkinson's disease therapy.
Junsang Yoo (2017)
10.1007/s11095-007-9514-y
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine
E. Esposito (2007)
10.1016/S0166-2236(98)01346-0
Analysing hippocampal function in transgenic mice: an ethological perspective
R. Gerlai (1999)
10.1016/j.jconrel.2016.05.044
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.
C. Saraiva (2016)
10.1007/BF02244551
Standardization of the rat paw formalin test for the evaluation of analgesics
H. Wheeler-Aceto (2005)
10.15419/BMRAT.V4I08.203
Evaluation of Quetiapine Fumarate and its Solid Lipid Nanoparticles as antipsychotic drug in rat model of schizophrenia
M. Said (2017)
10.1007/s11064-017-2444-0
Effects of Fish and Grape Seed Oils as Core of Haloperidol-Loaded Nanocapsules on Oral Dyskinesia in Rats
D. Benvegnú (2017)
Behavioral despair in mice: a primary screening test for antidepressants.
R. Porsolt (1977)
10.1186/1740-3391-2-2
Daily rhythm of nociception in rats
A. Christina (2004)
10.1007/s13311-016-0431-9
Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures
Y. Wang (2016)
10.3858/emm.2011.43.5.029
Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects
Y. S. Lee (2011)
10.1016/j.ijbiomac.2016.06.001
Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia.
N. Ahmad (2016)
10.5772/33251
Oxidative Therapy Against Cancer
M. Miguel (2012)
10.1021/nn506248s
Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Z. Cohen (2015)
10.2147/IJN.S128396
Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer’s disease treatment
Y. Kuo (2017)
10.7150/thno.16562
Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model
Shuiqin Niu (2017)
10.1080/10611860701725381
Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain
V. Soni (2008)
10.1111/j.1468-1331.2004.00942.x
Postural stability of Parkinson's disease patients is improved by decreasing rigidity
A. Bartolic (2005)
10.1016/J.ADDR.2004.07.004
Drug transfer in the choroid plexus. Multiplicity and substrate specificities of transporters
J. Ghersi-Egea (2004)
10.1039/c5mt00226e
Quantitative imaging of platinum based on laser ablation-inductively coupled plasma-mass spectrometry to investigate toxic side effects of cisplatin.
C. Köppen (2015)
10.1016/j.ultrasmedbio.2012.04.015
Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.
Lisa Treat (2012)
10.2147/IJN.S136401
Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts
Y. Shen (2017)
10.1006/exnr.2002.8021
Detection of Behavioral Impairments Correlated to Neurochemical Deficits in Mice Treated with Moderate Doses of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
J. Tillerson (2002)
10.1021/ACSNANO.6B04268
Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
Tingting Lin (2016)
10.3109/10717544.2016.1162878
Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics
Sonali (2016)
10.12659/MSM.894567
Treatment Efficacy of NGF Nanoparticles Combining Neural Stem Cell Transplantation on Alzheimer’s Disease Model Rats
Y. Chen (2015)
10.3109/1061186X.2010.483517
Poly(ethylene glycol)-block-poly(d,l-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery
J. Shen (2011)
10.1111/j.1460-9568.2007.06018.x
Neuroprotective effects of novel phosphatidylglycerol‐based phospholipids in the 6‐hydroxydopamine model of Parkinson's disease
S. Crotty (2008)
10.1074/jbc.273.35.22528
Mice with a Homozygous Null Mutation for the Most Abundant Glutathione Peroxidase, Gpx1, Show Increased Susceptibility to the Oxidative Stress-inducing Agents Paraquat and Hydrogen Peroxide*
J. D. de Haan (1998)
10.3109/02652049809006836
Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.
R. Alyautdin (1998)
10.1016/S0300-483X(99)00030-X
The antioxidant EPC-K1 attenuates NO-induced mitochondrial dysfunction, lipid peroxidation and apoptosis in cerebellar granule cells.
T. Wei (1999)
10.1097/RLI.0b013e318272d29f
A Historical Overview of Magnetic Resonance Imaging, Focusing on Technological Innovations
T. Ai (2012)
10.3109/1061186X.2012.747529
Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model
Mohammad Yusuf (2013)
10.1007/s00213-004-2048-7
Forced swimming test in mice: a review of antidepressant activity
B. Petit-Demoulière (2004)
10.1021/acschemneuro.6b00207
Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease.
Paromita Kundu (2016)
10.1016/j.jconrel.2014.06.006
Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain.
Sukrut Somani (2014)
10.1016/S0166-4328(01)00452-1
Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice
V. Carola (2002)
10.1016/j.jconrel.2010.11.013
Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology.
G. Mittal (2011)
10.1080/10611860903112842
Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
K. B. Kurakhmaeva (2009)
10.1007/978-1-60761-303-9
Mood and Anxiety Related Phenotypes in Mice
T. Gould (2009)
10.5607/en.2014.23.3.246
Increasing the Efficiency of Parkinson's Disease Treatment Using a poly(lactic-co-glycolic acid) (PLGA) Based L-DOPA Delivery System
P. Gambaryan (2014)
10.1016/S0896-6273(00)80108-7
Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme
N. Inestrosa (1996)
10.1016/0006-8993(87)90269-1
Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions
S. Dunnett (1987)
10.1016/j.ijpharm.2014.08.003
In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
S. Jose (2014)
10.1016/j.ijpharm.2011.07.021
Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery.
Yao Qin (2011)
10.1016/j.nano.2013.10.009
Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats.
Yingzheng Zhao (2014)
10.3109/10717544.2015.1094681
Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats
Sonali (2016)
10.1212/WNL.0b013e318285c135
The history of cerebral PET scanning
L. Portnow (2013)
10.1016/0028-3908(76)90115-5
Interaction of drug effects with testing procedures in the measurement of catalepsy
M. Stanley (1976)
10.3390/ijms15033612
Transport of Glial Cell Line-Derived Neurotrophic Factor into Liposomes across the Blood-Brain Barrier: In Vitro and in Vivo Studies
Shaoling Wu (2014)
10.1007/s00709-013-0516-9
A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke
Niyaz Ahmad (2013)
10.2147/IJN.S16570
Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles
Xin-hua Tian (2011)
10.2217/fon.09.109
Clinical implications of near-infrared fluorescence imaging in cancer.
N. Kosaka (2009)
10.1002/0471141755.ph0530s20
Social Recognition Task in the Rat
M. Lemaire (2003)
10.1093/neuonc/nou354
Convection-enhanced delivery for the treatment of glioblastoma.
M. Vogelbaum (2015)
10.1038/nature06917
Imaging in the era of molecular oncology
R. Weissleder (2008)
10.1016/j.neuint.2017.05.011
Cerium oxide nanoparticles could ameliorate behavioral and neurochemical impairments in 6-hydroxydopamine induced Parkinson's disease in rats
M. A. Hegazy (2017)
10.1016/0028-3908(71)90053-0
Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen.
B. Costall (1971)
10.2147/IJN.S125300
Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model
Wg singleton (2017)
10.1517/17425240903405581
Various drug delivery approaches to the central nervous system
S. Pasha (2010)
10.1016/j.expneurol.2007.12.015
Safety of real-time convection-enhanced delivery of liposomes to primate brain: A long-term retrospective
M. Krauze (2008)
10.1016/0003-9861(78)90479-4
Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase.
Y. Kono (1978)
10.1016/j.npep.2016.03.002
Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid β25–35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer's disease
Aishwarya Vedagiri (2016)
10.4103/0975-7406.130965
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Kanika Madaan (2014)
10.1016/j.nano.2008.12.003
PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation.
M. Muthu (2009)
10.2967/jnumed.106.032680
Recent Advances in SPECT Imaging
M. Madsen (2007)
10.1007/s40005-016-0274-8
Development, optimization and pharmacodynamic assessment of olanzapine based lipidic SNEDDS for proficient management of psychosis
M. Ahsan (2016)
10.1111/jphp.12481
Polysorbate 80‐coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain‐protective effects in rats
Deqing Sun (2015)
10.1016/S0006-8993(96)01162-6
Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test
G. Rozas (1997)
10.1002/jnr.21191
Oxidative damage in nucleic acids and Parkinson's disease
Y. Nakabeppu (2007)
10.1016/j.colsurfb.2015.03.022
Functionalized graphene oxide as a drug carrier for loading pirfenidone in treatment of subarachnoid hemorrhage.
Lijun Yang (2015)
10.2217/17435889.3.3.305
Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation.
M. Muthu (2008)
10.1080/02652048.2016.1234515
In vitro/in vivo evaluation of gamma-aminobutyric acid-loadedN,N-dimethylacrylamide-based pegylated polymeric nanoparticles for brain delivery to treat epilepsy
Gülsel Yurtdaş Kırımlıoğlu (2016)
10.1016/0304-3959(88)90026-7
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
K. Hargreaves (1988)
10.1007/s002130100811
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
M. Geyer (2014)
10.1021/acschemneuro.7b00189
Mass Spectrometric Imaging of Ceramide Biomarkers Tracks Therapeutic Response in Traumatic Brain Injury.
D. Barbacci (2017)
10.1002/cmdc.201600080
Albumin Nanoparticles for Brain Delivery: A Comparison of Chemical versus Thermal Methods and in vivo Behavior
M. Bergonzi (2016)
10.1369/0022155410395760
Histochemistry: live and in color.
L. Lavis (2011)
10.1007/978-1-61779-860-3_5
Detection of apoptosis by TUNEL assay.
K. Kyrylkova (2012)
10.1523/JNEUROSCI.15-07-05372.1995
Elevated body swing test: a new behavioral parameter for rats with 6- hydroxydopamine-induced hemiparkinsonism
C. Borlongan (1995)
10.1016/0006-8993(70)90187-3
Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.
U. Ungerstedt (1970)
10.1037/0735-7044.98.5.908
Chemosensory and hormonal mediation of social memory in male rats.
T. F. Sawyer (1984)
10.2147/IJN.S14737
Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment
A. C. Silva (2011)
10.1016/j.freeradbiomed.2011.09.030
Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations.
B. Kalyanaraman (2012)
10.1002/jnr.10389
Role of mitochondrial dysfunction in Alzheimer's disease
R. Castellani (2002)
10.3109/10717544.2015.1064186
Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy
Shuxin Song (2016)
10.1016/j.neuroscience.2009.02.008
Long-term administration of green tea catechins prevents age-related spatial learning and memory decline in C57BL/6 J mice by regulating hippocampal cyclic amp-response element binding protein signaling cascade
Q. Li (2009)
10.15171/apb.2015.043
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.
Neda Naseri (2015)
10.1016/0014-2999(93)90215-4
Repeated exposure to cocaine produces long-lasting deficits in the serotonergic stimulation of prolactin and renin, but not adrenocorticotropin secretion.
A. D. Levy (1993)
10.1586/14737175.6.10.1495
Advances in strategies to improve drug delivery to brain tumors
H. Newton (2006)
10.1016/0006-8993(76)90579-5
3-Methoxy-4-hydroxyphenylethyleneglycol (MHPG) transport from the spinal cord during spinal subarachnoid perfusion
J. Kessler (1976)
10.1038/35000576
Motor disorder in Huntington's disease begins as a dysfunction in error feedback control
M. Smith (2000)
10.1007/s11095-013-1005-8
Angiopep-Conjugated Nanoparticles for Targeted Long-Term Gene Therapy of Parkinson’s Disease
R. Huang (2013)
10.1037/H0043788
The relation between fear induced by novel stimulation and exploratory drive.
K. Montgomery (1955)
10.1016/j.jconrel.2017.08.033
Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases
C. Tapeinos (2017)
10.1080/10717544.2017.1377315
Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice
M. Yadav (2017)
10.1201/noe1420052343.ch2
Cued and Contextual Fear Conditioning for Rodents
P. Curzon (2009)
10.1097/00004647-200101000-00002
Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain
P. Chan (2001)
10.1016/J.BRAINRESPROT.2003.12.001
An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts.
Chintamani N. Joshi (2004)
10.1021/nn5014484
A Nanoparticle Carrying the p53 Gene Targets Tumors Including Cancer Stem Cells, Sensitizes Glioblastoma to Chemotherapy and Improves Survival
Sang-soo Kim (2014)
10.1016/j.ijpharm.2012.09.054
Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
S. Martins (2012)
10.2217/nnm.14.130
Applications of dendrimers for brain delivery and cancer therapy.
Sukrut Somani (2014)
10.1002/wnan.1446
Recent advances in aliphatic polyesters for drug delivery applications.
K. E. Washington (2017)
10.1371/journal.pone.0062425
Selective Targeting of Brain Tumors with Gold Nanoparticle-Induced Radiosensitization
D. Joh (2013)
10.1016/0013-4694(72)90177-0
Modification of seizure activity by electrical stimulation. II. Motor seizure.
R. Racine (1972)
10.1007/s00216-012-5973-z
Elemental imaging of MRI contrast agents: benchmarking of LA-ICP-MS to MRI
J. A. T. Pugh (2012)
10.1016/S0031-9384(96)00176-X
Of Mice and Mazes: Similarities Between Mice and Rats on Dry Land But Not Water Mazes
I. Whishaw (1996)
10.1016/0076-6879(67)10055-4
[52] Preparations and properties of soluble NADH dehydrogenases from cardiac muscle
T. E. King (1967)
10.1016/j.ijpharm.2011.09.008
Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals.
Yao Qin (2011)
10.1016/j.biomaterials.2010.03.011
A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery.
Y. Liu (2010)
10.1016/0304-3940(88)90497-1
Response latencies in the tail-flick test depend on tail skin temperature
O. Berge (1988)
10.1016/j.jconrel.2009.11.004
Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo.
A. L. Cardoso (2010)
10.3892/or.2011.1459
Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles.
L. Han (2012)
10.1016/j.jconrel.2011.02.022
Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration.
Ziyi Wen (2011)
10.3109/1061186X.2010.523787
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route
S. Patel (2011)
10.1016/S0301-0082(98)00045-8
The role of tumour necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system
M. Muñoz-Fernández (1998)
10.1021/nn4058215
Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer's disease by accelerating the clearance of amyloid-beta.
Qingxiang Song (2014)
10.1002/jgm.1361
Neuroprotection in a 6‐hydroxydopamine‐lesioned Parkinson model using lactoferrin‐modified nanoparticles
R. Huang (2009)
10.1016/j.neuint.2016.08.003
Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury
Yanlu Zhang (2017)
10.1016/j.jpsychires.2012.05.014
Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain.
M. I. Alam (2012)
10.1186/s13104-015-1116-x
The pattern of neurological diseases in elderly people in outpatient consultations in Sub-Saharan Africa
Kuate-Tegueu Callixte (2015)
10.1016/j.neurobiolaging.2004.08.012
Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats: Involvement of adenosine A1 and A2A receptors
Rui D S Prediger (2005)
10.1016/j.ejps.2012.12.007
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Shadab Md (2013)
10.2147/IJN.S80706
Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats
Mayur Bagad (2015)
10.1038/35050116
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D. Morgan (2000)
10.1007/s10517-015-2765-4
Site-Directed Delivery of VEGF-Targeted Liposomes into Intracranial C6 Glioma
S. Shein (2015)
10.1088/0957-4484/23/16/165101
Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain.
Yong Lin (2012)
10.1038/nn1394
Prefrontal white matter volume is disproportionately larger in humans than in other primates
P. T. Schoenemann (2005)
A simple quantitative bradykinesia test in MPTP-treated mice.
N. Ogawa (1985)
10.1016/j.brainres.2008.01.039
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease
B. Wilson (2008)
10.1016/j.jneumeth.2007.06.032
Automation of the novel object recognition task for use in adolescent rats
J. M. Silvers (2007)
10.1016/j.ijpharm.2014.02.013
A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Congcong Lin (2014)
10.1155/2014/780179
Mitochondrial Dysfunction: Different Routes to Alzheimer's Disease Therapy
P. Picone (2014)
10.1007/s12035-015-9635-y
Enhanced Therapeutic Potential of Nano-Curcumin Against Subarachnoid Hemorrhage-Induced Blood–Brain Barrier Disruption Through Inhibition of Inflammatory Response and Oxidative Stress
Zong-yong Zhang (2015)
10.1016/S0169-328X(97)00313-6
Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage.
M. Weisbrot-Lefkowitz (1998)
10.1002/MAS.20124
Imaging mass spectrometry.
L. McDonnell (2007)
10.1007/s002130100687
Limitations on the use of the C57BL/6 mouse in the tail suspension test
A. J. Mayorga (2014)
10.1006/PHRS.2000.0672
Decreased body temperature dependent appearance of behavioral despair in the forced swimming test in mice.
I. Arai (2000)
10.1016/J.PNPBP.2007.08.025
The amphetamine-induced sensitized state as a model of schizophrenia
R. Featherstone (2007)
10.1016/B978-1-4377-0310-8.00002-6
Chapter 2 – Pharmacokinetics
S. Bardal (2011)
[Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes].
M. Budai (2001)
10.1016/0166-4328(94)90078-7
Behavioral impairment in radial-arm maze learning and acetylcholine content of the hippocampus and cerebral cortex in aged mice
S. Ikegami (1994)
10.1016/j.copbio.2015.03.016
Developing injectable nanomaterials to repair the heart.
Mary M Nguyen (2015)
10.3109/10717544.2014.909907
Solubilized delivery of paliperidone palmitate by d-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management
M. Muthu (2016)
10.1016/j.biomaterials.2013.08.083
Polybutylcyanoacrylate nanoparticles for delivering hormone response element-conjugated neurotrophin-3 to the brain of intracerebral hemorrhagic rats.
Chiu-Yen Chung (2013)
10.3109/1061186X.2011.639022
Comparison of four different peptides to enhance accumulation of liposomes into the brain
Yao Qin (2012)
10.1155/2017/9090325
Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer
S. Jahan (2017)
10.1007/BF02834296
Brain glutathione peroxidase in neurodegenerative disorders.
S. Kish (1986)
10.1039/c003875j
Bioimaging of copper alterations in the aging mouse brain by autoradiography, laser ablation inductively coupled plasma mass spectrometry and immunohistochemistry.
L. Wang (2010)
10.1037/0033-2909.83.3.482
The Open-Field Test: a critical review.
R. Walsh (1976)
10.1080/10717544.2017.1402218
Reduction-responsive PEtOz-SS-PCL micelle with tailored size to overcome blood–brain barrier and enhance doxorubicin antiglioma effect
Yuling Li (2017)
10.1111/j.1460-9568.2006.04699.x
Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat
T. Freret (2006)
10.1002/HIPO.20356
Differential involvement of the dorsal hippocampus in passive avoidance in C57bl/6J and DBA/2J mice
Petra J.J. Baarendse (2008)
10.1038/nnano.2014.84
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.
James E. Dahlman (2014)
10.1089/NEU.1996.13.557
An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits.
Y. Chen (1996)
10.1016/j.expneurol.2005.06.017
Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice
M. Starkey (2005)
10.1208/s12248-012-9444-4
Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood–Brain Barrier Model and in Alzheimer’s Disease Tg2576 Mice
Kwok Kin Cheng (2012)
10.1111/J.1365-201X.1971.TB11000.X
Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.
U. Ungerstedt (1971)
NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants.
A. Granholm (1994)
10.3389/fnagi.2018.00244
EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer’s Disease
N. Singh (2018)
10.1007/BF00428203
The tail suspension test: A new method for screening antidepressants in mice
L. Steru (2004)
10.1016/j.biomaterials.2013.07.081
Multifunctional receptor-targeted nanocomplexes for the delivery of therapeutic nucleic acids to the brain.
G. D. Kenny (2013)
10.1172/JCI22831
Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.
B. Gong (2004)
10.1074/jbc.M308643200
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes*
N. D. Sonawane (2003)
10.1002/ijc.20048
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
S. C. Steiniger (2004)
10.1016/j.ijpharm.2010.10.005
Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Hongliang Xin (2010)
10.1146/ANNUREV.NEURO.27.070203.144157
The amygdala modulates the consolidation of memories of emotionally arousing experiences.
J. D. McGaugh (2004)
10.1016/j.jconrel.2015.09.057
Self-assembled 20-nm (64)Cu-micelles enhance accumulation in rat glioblastoma.
J. Seo (2015)
10.1016/S0166-4328(03)00115-3
Stereotypies in caged parrots, schizophrenia and autism: evidence for a common mechanism
J. Garner (2003)
10.1016/j.jconrel.2016.06.005
MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease.
C. Saraiva (2016)
10.1007/s13361-017-1665-4
Laser Desorption/Ionization Mass Spectrometric Imaging of Endogenous Lipids from Rat Brain Tissue Implanted with Silver Nanoparticles
L. Muller (2017)
10.1016/j.biocel.2016.09.002
Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury.
A. Kalani (2016)
10.1093/OXFORDJOURNALS.SCHBUL.A033326
Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia.
N. Swerdlow (1998)
10.1016/j.ejps.2015.06.024
Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain.
A. Zarebkohan (2015)
10.1016/0006-2952(84)90353-8
Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney. Possible implications in analgesic nephropathy.
J. Mohandas (1984)
10.1023/A:1016083113123
Chemotherapeutic Drugs Released from Polymers: Distribution of 1,3-bis(2-chloroethyl)-l-nitrosourea in the Rat Brain
L. Fung (2004)
10.1007/s13346-010-0001-3
Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumors
Andrew J. Sawyer (2010)
10.1021/acsami.6b02838
Superparamagnetic Iron Oxide Nanoparticles Modified with Tween 80 Pass through the Intact Blood-Brain Barrier in Rats under Magnetic Field.
Yinping Huang (2016)
10.1038/nnano.2014.274
Squalenoyl Adenosine Nanoparticles provide Neuroprotection after Stroke and Spinal Cord Injury
Alice Gaudin (2014)
10.1016/j.biomaterials.2011.07.004
Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Jianwei Guo (2011)
10.1242/jeb.01022
Oxidants, antioxidants and the ischemic brain
D. Warner (2004)
10.1021/acs.molpharmaceut.5b00402
Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer.
Y. K. Katare (2015)
Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines.
N. Eddy (1953)
The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.
B. Angrist (1970)
10.1016/0023-9690(81)90020-5
Spatial Localization Does Not Require the Presence of Local Cues
R. Morris (1981)
10.3390/ijms19010205
Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration
B. Pham (2018)
10.1016/j.jconrel.2016.01.046
Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Hyeong Jun Byeon (2016)
10.1093/INTIMM/7.3.481
Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1.
B. Engelhardt (1995)
10.1523/JNEUROSCI.15-05-03863.1995
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
M. Olsson (1995)
10.1016/j.bbr.2005.02.023
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice
R. Iancu (2005)
10.1016/j.ejphar.2014.11.014
Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence.
Anand Kamal Sachdeva (2015)
10.2307/1420860
Effects of strain, sex, and illumination on open-field behavior of rats.
F. Valle (1970)
10.1016/j.biomaterials.2015.11.060
Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice.
Yifeng Liu (2016)
10.1016/j.jconrel.2009.09.020
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
X. Ying (2010)
10.3390/nano6040076
Multifunctional Inorganic Nanoparticles: Recent Progress in Thermal Therapy and Imaging
Kondareddy Cherukula (2016)
10.1016/j.biomaterials.2011.03.031
Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.
J. Li (2011)
10.1037/0735-7044.102.5.748
The catalepsy test: its ups and downs.
P. Sanberg (1988)
10.1021/acs.molpharmaceut.7b00374
Pluronic P85/F68 Micelles of Baicalein Could Interfere with Mitochondria to Overcome MRP2-Mediated Efflux and Offer Improved Anti-Parkinsonian Activity.
Tongkai Chen (2017)
10.1523/JNEUROSCI.17-22-08695.1997
Peroxide Modulation of Slow Onset Potentiation in Rat Hippocampus
J. Auerbach (1997)
10.1016/j.ijpharm.2010.10.015
Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Y. Çırpanlı (2011)
10.1166/JNN.2003.077
Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
J. Kreuter (2004)
10.1016/j.ejps.2016.05.012
Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
Eameema Muntimadugu (2016)
A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
F. E. D'amour (1941)
10.1089/rej.2008.0677
Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?
C. Lemere (2008)
10.1155/2013/238428
Nanoparticles for Brain Drug Delivery
M. Masserini (2013)
10.1016/J.JCONREL.2006.10.015
Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants.
B. Petri (2007)
10.1016/j.nano.2014.05.012
A self-assembling nanomaterial reduces acute brain injury and enhances functional recovery in a rat model of intracerebral hemorrhage.
Lynn Yan-Hua Sang (2015)
10.1016/0076-6879(67)10061-X
[58] Preparation of succinate dehydrogenase and reconstitution of succinate oxidase
T. E. King (1967)
10.1002/mabi.201500058
Dexamethasone-Conjugated Polyamidoamine Dendrimer for Delivery of the Heme Oxygenase-1 Gene into the Ischemic Brain.
Pureum Jeon (2015)
Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.
A. Abuchowski (1977)
10.3181/00379727-47-13084P
Immunological Properties of an Antibody Containing a Fluorescent Group.∗
A. H. Coons (1941)
Administration of substances to laboratory animals: routes of administration and factors to consider.
P. Turner (2011)
10.1007/s11095-011-0440-7
Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration
T. Kanazawa (2011)
10.1016/0165-0270(85)90116-5
Formalin test in mice, a useful technique for evaluating mild analgesics
S. Hunskaar (1985)
10.1016/j.jneumeth.2008.10.030
The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease
R. Silvestrin (2009)
10.1016/j.jconrel.2016.01.017
Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model.
Yingzheng Zhao (2016)
10.1016/0024-3205(88)90551-6
The Paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism.
B. Ellenbroek (1988)
10.1016/j.ijpharm.2011.05.062
Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.
Kai-li Hu (2011)
10.1016/j.ejpb.2012.10.019
Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment.
A. Zanotto-Filho (2013)
10.1073/PNAS.88.11.4771
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.
P. M. Friden (1991)
10.1186/1476-511X-11-72
Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine
Rahul S. Nair (2012)
10.1016/j.neuint.2012.06.015
Haloperidol-loaded polysorbate-coated polymeric nanocapsules decrease its adverse motor side effects and oxidative stress markers in rats
D. Benvegnú (2012)
10.1016/S0031-9384(02)00941-1
Longitudinal study of daily variation of rats' behavior in the elevated plus-maze
Miriam Mendonça Morato Andrade (2003)
10.1016/j.nbd.2003.12.016
The blood–brain barrier: an overview: Structure, regulation, and clinical implications
P. Ballabh (2004)
10.1002/jgm.659
Lipid‐mediated siRNA delivery down‐regulates exogenous gene expression in the mouse brain at picomolar levels
Z. Hassani (2005)
10.1002/RCM.5281
Molecular histology analysis by matrix-assisted laser desorption/ionization imaging mass spectrometry using gold nanoparticles as matrix.
Ho-Wai Tang (2011)
10.1126/SCIENCE.8420006
Blood-brain barrier penetration and in vivo activity of an NGF conjugate.
P. Friden (1993)
10.1016/j.ejpb.2009.09.003
Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
S. Gelperina (2010)
10.1016/j.biomaterials.2012.06.063
Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor.
R. Prades (2012)
10.1016/j.neuint.2015.07.026
Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of NMRI mice – Impact on bioavailability
S. Hagl (2015)
10.1021/mp300391v
In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry.
L. Albertazzi (2013)
10.1037/H0058536
VTE on an elevated T-maze.
L. Jackson (1943)
10.1002/jps.24044
Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogram.
G. Leyva-Gómez (2014)
10.1007/s10856-013-4965-7
Novel surface modified polymer–lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation
C. Pardeshi (2013)
10.1016/j.canlet.2013.02.019
Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth.
M. Katakowski (2013)
10.1152/PHYSREV.1979.59.3.527
Hydroperoxide metabolism in mammalian organs.
B. Chance (1979)
Lipid-DNA and lipid-polyelectrolyte mesophases: structure and exchange kinetics.
F. Artzner (2000)
10.1016/j.nbd.2008.03.008
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy
M. Grounds (2008)
10.1016/j.ijpharm.2013.02.014
Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A.
Pratikkumar A. Patel (2013)
10.1007/s00213-002-1335-4
Antidepressant-like effects in various mice strains in the forced swimming test
D. David (2003)
10.5414/NPP28153
Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects.
T. Hekmatara (2009)
10.1161/HS0302.103745
Manganese Superoxide Dismutase Deficiency Exacerbates Cerebral Infarction After Focal Cerebral Ischemia/Reperfusion in Mice: Implications for the Production and Role of Superoxide Radicals
G. Kim (2002)
10.1007/BF00504983
Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behaviour
S. Handley (2004)
10.1016/S0169-328X(00)00049-8
Impairment of brain mitochondrial function by hydrogen peroxide.
N. Sims (2000)
10.1016/J.BIOMATERIALS.2005.12.021
Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
D. Kim (2006)
10.1016/0091-3057(95)02083-7
Effects of neonatal dopamine depletion on sensory inhibition in the rat
K. Stevens (1996)
10.1248/BPB.B12-00769
The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury.
Li-xia Zhao (2013)
10.1177/007327537701500201
The History of Histology: A Brief Survey of Sources
B. Bracegirdle (1977)
10.1021/acsnano.7b07625
Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer's Disease.
Q. Chen (2018)
10.1002/ANA.410320706
Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress
R. Floyd (1992)
10.1056/NEJMRA023144
Molecular mechanisms of amyloidosis.
G. Merlini (2003)
10.1016/j.nano.2015.12.387
A self-assembly peptide nanofibrous scaffold reduces inflammatory response and promotes functional recovery in a mouse model of intracerebral hemorrhage.
N. Zhang (2016)
10.1002/adhm.201701070
Advances in Stimulus‐Responsive Polymeric Materials for Systemic Delivery of Nucleic Acids
Minjie Sun (2018)
10.1016/0091-3057(93)90370-9
Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum
Jennifer M. Klug (1993)
10.1016/j.ijpharm.2014.07.025
Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
Yasmine M Gabal (2014)
10.1002/cmmi.1530
Radiolabeling approaches of nanoparticles with (99m) Tc.
D. Psimadas (2013)
10.3109/10717544.2015.1049719
Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo
Y. Chen (2016)
10.1016/J.CES.2005.06.019
Inorganic nanoparticles as carriers for efficient cellular delivery
Z. P. Xu (2006)
10.1016/j.nano.2014.01.003
Magnetic micelles for DNA delivery to rat brains after mild traumatic brain injury.
Mahasweta Das (2014)
10.1016/0031-9384(82)90184-6
Shortened pain response time following repeated algesiometric tests in rats
Y. Lai (1982)
10.1016/j.biomaterials.2014.10.007
Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
Shaobo Ruan (2015)
10.1021/acsami.6b05572
T7 Peptide-Functionalized PEG-PLGA Micelles Loaded with Carmustine for Targeting Therapy of Glioma.
Yunke Bi (2016)
10.1016/j.colsurfb.2015.06.025
A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease.
Fanfei Meng (2015)
10.1615/CRITREVTHERDRUGCARRIERSYST.V18.I1.10
Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting.
S. Vyas (2001)
10.1016/S0165-0270(96)02211-X
Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion
Kouji Matsuura (1997)
10.1016/j.addr.2011.12.006
Polymeric nanoparticles for drug delivery to the central nervous system.
T. Patel (2012)
10.2147/IJN.S133166
Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
J. Tang (2017)
10.1088/0957-4484/21/40/405101
Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
Shu-Hui Hsu (2010)
10.2147/IJN.S39232
Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer’s disease
M. Ismail (2013)
In vivo bioluminescence imaging.
A. Sato (2004)
10.2217/nnm.12.2
Redox nanoparticle treatment protects against neurological deficit in focused ultrasound-induced intracerebral hemorrhage.
Pennapa Chonpathompikunlert (2012)
10.2147/IJN.S94336
Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration
T. Miyazawa (2015)
10.1002/ana.20101
Progressive age‐related development of Alzheimer‐like pathology in APP/PS1 mice
F. Trinchese (2004)
10.1080/10408360500523878
Glutathione in Cancer Biology and Therapy
J. Estrela (2006)
10.1089/NEU.2005.22.947
Early Glasgow Outcome Scale scores predict long-term functional outcome in patients with severe traumatic brain injury.
J. King (2005)
10.1016/j.peptides.2018.01.002
Recent insights in the use of nanocarriers for the oral delivery of bioactive proteins and peptides
P. Batista (2018)
10.1212/01.WNL.0000161874.52302.5D
[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease
A. Siderowf (2005)
10.1016/0014-2999(78)90251-0
Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.
B. Costall (1978)
10.1111/jnc.13997
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia
A. D. Andersen (2017)
10.1016/j.neubiorev.2005.04.017
Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on
A. Carobrez (2005)
10.3171/JNS.1991.74.3.0441
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.
H. Brem (1991)
10.1111/j.1460-9568.2007.05653.x
The corticotrophin‐releasing factor‐like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease
A. Abuirmeileh (2007)
10.1097/00008877-200505000-00002
Effects of ultra-low doses of morphine, naloxone and ethanol on morphine state-dependent memory of passive avoidance in mice
K. Tayebi Meybodi (2005)
10.1016/0304-3959(96)03048-5
Individual differences in the hotplate test and effects of habituation on sensitivity to morphine
M. Plone (1996)
10.1016/j.biomaterials.2012.07.046
Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
Hongliang Xin (2012)
10.1161/STROKEAHA.111.637090
Nanoerythropoietin Is 10-Times More Effective Than Regular Erythropoietin in Neuroprotection in a Neonatal Rat Model of Hypoxia and Ischemia
H. Chen (2012)
10.1620/TJEM.221.257
Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts.
Michiko Yokosawa (2010)
10.1016/j.jconrel.2017.03.037
GRP78 enabled micelle‐based glioma targeted drug delivery
D. Ran (2017)
10.1016/0165-0270(89)90124-6
An improved method for tail-flick testing with adjustment for tail-skin temperature
A. Tjølsen (1989)
10.1016/j.jneuroim.2007.12.005
Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles
T. Schneider (2008)
10.1016/0003-2697(82)90118-X
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.
L. C. Green (1982)
10.2147/IJN.S145488
mPEG-PLA/TPGS mixed micelles via intranasal administration improved the bioavailability of lamotrigine in the hippocampus
Anan Yu (2017)
10.1208/s12248-015-9780-2
A Review of Clinical Translation of Inorganic Nanoparticles
Aaron C. Anselmo (2015)
10.1038/sj.gt.3302516
Tf-lipoplex-mediated NGF gene transfer to the CNS: neuronal protection and recovery in an excitotoxic model of brain injury
M. D. Cruz (2005)
10.2217/nnm.15.173
Phenytoin carried by silica core iron oxide nanoparticles reduces the expression of pharmacoresistant seizures in rats.
Argelia Rosillo-de la Torre (2015)
10.3109/10717544.2015.1081994
Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models
R. Zhang (2016)
10.1017/S1092852900010427
The role of glutamate in anxiety and related disorders.
B. Cortese (2005)
10.1523/JNEUROSCI.3080-04.2004
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein
S. Fleming (2004)
10.1016/j.biomaterials.2011.02.044
Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
Hongliang Xin (2011)
10.1111/J.1365-2125.1993.TB04154.X
Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor.
C. Weller (1993)
10.1111/j.1600-0447.1996.tb09814.x
Catatonia. I. Rating scale and standardized examination
G. Bush (1996)
10.1016/j.expneurol.2005.08.016
Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain
Ryuta Saito (2005)
10.1016/S0892-0362(03)00073-4
Factors affecting grip strength testing.
J. Maurissen (2003)
10.1016/J.BRAINRESREV.2006.08.001
Congo red and protein aggregation in neurodegenerative diseases
Petrea Frid (2007)
10.1096/fj.08-116947
Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury
M. K. Reddy (2009)
10.1523/JNEUROSCI.0143-07.2008
Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration
H. Gao (2008)
10.1016/J.BIOMATERIALS.2007.09.024
The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain.
R. Huang (2008)
10.1023/A:1022604120952
Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles
J. Kreuter (2004)
10.1369/0022155414546692
Comparative Analysis of H&E and Prussian Blue Staining in a Mouse Model of Cerebral Microbleeds
S. Liu (2014)
10.1016/j.nano.2009.04.001
Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine.
B. Wilson (2010)
10.1002/asia.201100570
Cyclic RGD-polyethylene glycol-polyethylenimine for intracranial glioblastoma-targeted gene delivery.
C. Zhan (2012)
10.1016/B978-0-12-382008-2.00001-5
Origins and Phylogenetic Relationships of the Laboratory Mouse
J. Guénet (2012)
10.1073/PNAS.93.18.9782
Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.
R. Lebovitz (1996)
10.1023/A:1018983904537
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
A. Gulyaev (2004)
10.1023/A:1012098005098
Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles
R. Alyautdin (2004)
10.1161/01.STR.17.3.472
Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.
J. Bederson (1986)
10.1016/j.ijpharm.2013.11.049
Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.
C. Zhang (2014)
10.1016/0014-2999(72)90086-6
Morphine catalepsy in the rat: relation to striatal dopamine metabolism.
K. Kuschinsky (1972)
10.1016/J.IJPHARM.2006.10.021
Nanoparticles--a historical perspective.
J. Kreuter (2007)
10.2174/138161210790170085
Conditioned avoidance response in the development of new antipsychotics.
M-L G Wadenberg (2010)
10.1016/j.bbr.2011.12.042
Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: Evidence that at a very low dose haloperidol acts as an indirect dopamine agonist
F. Dias (2012)
10.1016/S0149-7634(02)00103-3
Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive
E. Chesler (2002)
10.1016/j.nbd.2010.09.016
Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism
C. Glorioso (2011)
10.1021/nn504210g
Brain-Penetrating Nanoparticles Improve Paclitaxel Efficacy in Malignant Glioma Following Local Administration
E. Nance (2014)
10.1007/s12274-017-1478-6
Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage
D. W. Kang (2017)
10.1016/S0028-3908(00)00005-8
CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury
T. Schallert (2000)
10.1038/ncb1596
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
H. Valadi (2007)
10.1016/j.ejpb.2013.02.005
Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats.
V. Kakkar (2013)
10.2217/rme-2016-0032
Effect of mesenchymal stem cells and galantamine nanoparticles in rat model of Alzheimer's disease.
S. Misra (2016)
10.1016/j.ijpharm.2017.05.051
Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances.
Sanela M. Đorđević (2017)
10.1093/brain/awr348
Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43
Azusa Uchida (2012)
10.1096/fj.04-2751com
Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease
W. Zhang (2005)
10.1038/srep16589
Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel
B. Wang (2015)
10.15171/bi.2015.20
Reliability of malondialdehyde as a biomarker of oxidative stress in psychological disorders
Maryam Khoubnasabjafari (2015)
10.1016/S0091-3057(00)00392-0
Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3α,5α-THP
C. Frye (2000)
10.1038/s41598-017-01819-9
Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation
M. Rodríguez (2017)
10.1023/A:1010910523202
Receptor-Mediated Gene Targeting to Tissues In Vivo Following Intravenous Administration of Pegylated Immunoliposomes
N. Shi (2004)
10.1371/journal.pone.0132266
Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma
Azeem Arshad (2015)
10.2307/1416495
The Behavior of Organisms: An Experimental Analysis
B. Skinner (2016)
10.1039/b916722f
Bioimaging of metals in brain tissue by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) and metallomics.
J. S. Becker (2010)
10.1016/0166-4328(90)90122-U
Functional subdivisions of the rat somatic sensorimotor cortex
T. M. Barth (1990)
10.1002/0471141755.ph0508s49
Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice
V. Castagné (2010)
10.1016/j.ejpb.2009.11.001
Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
T. Parikh (2010)
10.1038/nprot.2013.155
Object recognition test in mice
M. Léger (2013)
10.1016/j.jneumeth.2009.07.010
Improved method for combination of immunocytochemistry and Nissl staining
A. Kádár (2009)
10.1166/JBN.2013.1597
An intrinsic therapy of gold nanoparticles in focal cerebral ischemia-reperfusion injury in rats.
Zhengxia Liu (2013)
10.1016/j.pnpbp.2017.07.025
Curcumin-loaded chitosan-alginate-STPP nanoparticles ameliorate memory deficits and reduce glial activation in pentylenetetrazol-induced kindling model of epilepsy
Mona Hashemian (2017)
10.1371/journal.pone.0062905
Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease
Y. Liu (2013)
10.1080/10611860400011406
Enhanced Tumour Uptake of Doxorubicin Loaded Poly(butyl cyanoacrylate) Nanoparticles in Mice Bearing Dalton's Lymphoma Tumour
L. H. Reddy (2004)
10.1016/j.nano.2016.02.004
In vitro and in vivo evaluation of functionalized chitosan-Pluronic micelles loaded with myricetin on glioblastoma cancer.
G. Wang (2016)
10.1073/pnas.1217508110
Impaired learning resulting from Respiratory Syncytial Virus infection
J. Espinoza (2013)
10.3892/mmr.2014.3017
Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles.
A. Li (2015)
10.1016/j.addr.2013.08.008
Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?
J. Kreuter (2014)
10.1016/S0166-4328(03)00117-7
Performance of different mouse strains in an object recognition task
A. Şık (2003)
10.1016/0304-3959(77)90130-0
The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats
D. Dubuisson (1978)
10.1155/2013/794582
Synthesis of Alginate-Curcumin Nanocomposite and Its Protective Role in Transgenic Drosophila Model of Parkinson's Disease
Y. Siddique (2013)
10.3390/ijms161226166
Intravenous Administration of Cilostazol Nanoparticles Ameliorates Acute Ischemic Stroke in a Cerebral Ischemia/Reperfusion-Induced Injury Model
N. Nagai (2015)
10.1037//0735-7044.110.1.117
HemiParkinson analogue rats display active support in good limbs versus passive support in bad limbs on a skilled reaching task of variable height.
E. Miklyaeva (1996)
10.3389/fchem.2014.00109
The application of magnetic nanoparticles for the treatment of brain tumors
K. Mahmoudi (2014)
10.2147/IJN.S124276
The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
Y. Wang (2017)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar